What is the normal progesterone to estrogen ratio?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 16, 2025 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

From the FDA Drug Label

The clinical relevance of the in vitro findings is unknown Coadministration of conjugated estrogens and progesterone capsules to 29 postmenopausal women over a 12-day period resulted in an increase in total estrone concentrations (Cmax 3.68 ng/mL to 4.93 ng/mL) and total equilin concentrations (Cmax 2.27 ng/mL to 3.22 ng/mL) and a decrease in circulating 17β estradiol concentrations (Cmax 0.037 ng/mL to 0. 030 ng/mL). TABLE 2. Mean (± S.D.) Pharmacokinetic Parameters for Estradiol, Estrone, and Equilin Following Coadministration of Conjugated Estrogens 0. 625 mg and Progesterone Capsules 200 mg for 12 Days to Postmenopausal Women Conjugated EstrogensConjugated Estrogens plus Progesterone Capsules DrugCmax (ng/mL)Tmax (hr)AUC(0-24h) (ng × h/mL)Cmax (ng/mL)Tmax (hr)AUC(0-24h) (ng × h/mL) Estradiol 0.037 ± 0.04812.7 ± 9.10.676 ± 0.7370.030 ± 0.03217.32 ± 1.210.561 ± 0.572 Estrone Total a 3.68 ± 1.5510.6 ± 6.861.3 ± 26.364.93 ± 2.077.5 ± 3.885.9 ± 41. 2 Equilin Total a2.27 ± 0.956.0 ± 4.028.8 ± 13.03.22 ± 1.135.3 ± 2.638.1 ± 20.2

The normal progesterone estrogen ratio is not explicitly stated in the provided drug label. However, the label does provide information on the pharmacokinetic parameters of progesterone and estrogen when coadministered.

  • The label reports an increase in total estrone concentrations and total equilin concentrations, and a decrease in circulating 17β estradiol concentrations when conjugated estrogens and progesterone capsules are coadministered.
  • The exact ratio of progesterone to estrogen is not provided, and therefore, no conclusion can be drawn regarding the normal progesterone estrogen ratio 1.

From the Research

The normal progesterone to estrogen ratio varies throughout a woman's menstrual cycle, with no single "ideal" ratio, as these hormones naturally fluctuate in relation to each other throughout the cycle. During the follicular phase, estrogen is dominant with levels ranging from 20-400 pg/mL, while progesterone remains low at about 0.1-1.5 ng/mL 2. At ovulation, estrogen peaks at 100-400 pg/mL. In the luteal phase, progesterone becomes dominant, rising to 2-25 ng/mL, while estrogen levels reach a second, smaller peak of 100-300 pg/mL. This shifting ratio is essential for normal reproductive function, as estrogen builds the uterine lining while progesterone prepares it for potential implantation. Some key points to consider include:

  • Hormone balance rather than a specific ratio is what matters for reproductive and overall health 3.
  • Significant deviations from these patterns may indicate conditions like estrogen dominance, anovulation, or luteal phase defects, which might require medical evaluation 4.
  • The use of progesterone and estrogen in hormone replacement therapy (HRT) is well established, with progesterone acting to counteract the proliferative effects of estradiol on the endometrium 3.
  • Recent data suggest that micronized progesterone may be safer for the breast, but less efficient than synthetic progestin on the endometrium 3. Overall, the balance between progesterone and estrogen is crucial for maintaining normal reproductive function and overall health in women, and any significant deviations from normal patterns should be evaluated and addressed by a healthcare professional.

Related Questions

How should I manage a 47‑year‑old woman who is still menstruating but has menopausal symptoms, with progesterone 1.5 ng/mL, follicle‑stimulating hormone (FSH) 5.9 IU/L, luteinizing hormone (LH) 5.3 IU/L, estradiol 69 pg/mL, serum iron 46 µg/dL, ferritin 30 ng/mL, and normal thyroid function?
In a 54-year-old woman using Bi‑Est (transdermal estriol/estradiol) 2.5 mg daily (80 % estriol/20 % estradiol) and oral micronized progesterone 50 mg daily, can this regimen cause spotting?
What is the appropriate management of a 54‑year‑old woman who has been amenorrheic for ≥5 years, has a Mirena intrauterine device in place beyond the approved 5‑year duration, is using an estradiol patch (0.1 mg) and oral micronized progesterone (100 mg daily) started three months ago, and now presents with two weeks of hormonal symptoms, mild vaginal bleeding, uterine cramping, and worsening varicose veins and lipedema?
What are the consequences of a 55‑year‑old woman with an intact uterus taking two daily 100 mg Prometrium (micronized progesterone) capsules instead of the prescribed one while on Oestrogel (estradiol) transdermal hormone replacement therapy?
In a 43-year-old woman with progesterone <0.5 ng/mL, estradiol <30 pg/mL, luteinizing hormone ≈12 IU/L, follicle‑stimulating hormone ≈9 IU/L, total testosterone 23 ng/dL, free testosterone 2.9 pg/mL, and sex hormone‑binding globulin 82 nmol/L, what is the most likely diagnosis and what is the appropriate first‑line management?
What are the implications of asymptomatic tachycardia (rapid heart rate)?
What is the relationship between Mixed Connective Tissue Disease (MCTD) and leflunomide?
What are the cardiac effects of glycopyrrolate (glycopyrrolate)?
What is the differential diagnosis for a patient with contact dermatitis due to Toxicodendron radicans (poison ivy) exposure?
Is endoscopy recommended for children with celiac disease (CD)?
What is the guide for Penicillin (antibiotic) desensitization?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.